Furthermore, we found that bronchogenic carcinoma cells were still sensitive to CSC-induced FANCD2 downregulation and thus CIN, but were at least in part resistant to CSC-induced apoptosis. Here, FANCD2 is linked to bronchogenic carcinoma.